SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alnylam Pharmaceuticals, Inc. (ALNY)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
166 29 0 ALNY
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
141Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First EA.J. Mullen-12/1/2008
140Seems like the best or low hanging fruit potential is in diseases targeting the rkrw-8/21/2008
139For a more positive view on RNAi's potential, you might want to check out thBulbaMan-8/21/2008
138Derek Lowe and Leerink Swann diss ALNY and the whole RNAi therapeutic field. LStuck-8/21/2008
137Takeda partnership gains $100M upfront payment, $50M near term tech work paymentpgo-neil-5/27/2008
136Glaxo and Regulus Ink Deal on Small, Small RNA Posted by Sarah Rubenstein Big PA.J. Mullen-4/17/2008
135Cross posting from RNAi thread interesting new work that finds darn near any siRtuck-3/28/2008
134Hi All, Anyone following the conference today? ALNY is dropping like a stone. Thomas-3/17/2008
133ANLY reports phase-2 RSV data: siliconinvestor.comDewDiligence_on_SI-2/29/2008
132Alnylam Reports Pre-clinical Progress with RNAi Therapeutics in Neurological DisLJM-2/7/2008
131Alnylam Launches its RNAi 2010 Outlook for Key Scientific, Clinical, and BusinesA.J. Mullen-1/7/2008
130Alnylam Presents First Ever Non-Human Primate Data with an RNAi Therapeutic TargA.J. Mullen-10/8/2007
129Congrats.keokalani'nui-9/28/2007
128Two points in two days is good enough for me, though. Closed the position, and tuck-9/28/2007
127>>With the chart the way it looks I wouldn't be selling naked calls (Ituck-9/28/2007
126Zacks analyst never liked ALNY, and for some reason was always somewhat behind ohmpa-9/26/2007
125Glad I waited a bit, but shorted via naked calls this afternoon. So far, so gootuck-9/26/2007
124Alnylam and Collaborators Publish New Paper in the Journal Nature on the In VivoLJM-9/26/2007
123Me three.DewDiligence_on_SI-9/19/2007
122I've got to say I'm tempted to do something like that myself. Cheers, tuck-9/19/2007
121I just bought some alny puts, for kicks. A massive MC and a long, long way to gkeokalani'nui-9/19/2007
120Merck is challenging some of the ALNY IP, so it's kind of hard to maintain atuck-9/19/2007
119Alnylam Announces the Termination of its Collaboration with Merck & Co., Incnigel bates-9/19/2007
118Alnylam Awarded $38.6 Million U.S. Government Contract to Develop RNAi TherapeutA.J. Mullen-8/9/2007
117Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAA.J. Mullen-7/30/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News